Evaluation of rheumatoid arthritis and connective tissue disease-related interstitial lung disease with pulmonary physiologic test, HRCT, and patient-based measures of dyspnea and functional disability
Tóm tắt
We aim to investigate the relationship between pulmonary function and imaging parameters with symptom-related patient-reported outcome measures (PROs). We included 65 patients of rheumatoid arthritis (RA) and connective tissue disease (CTD) with and without interstitial lung disease (ILD) into this cross-sectional study. We evaluated the relationship between FVC, DLco, and PROs and compared to HRCT findings. PROs included visual analogue scale for breathing, modified Borg scale, medical research council dyspnea scale, St. George’s respiratory questionnaire (SGRQ), Leicester cough questionnaire, and Short Form 36 quality of life (SF-36 QoL). The mean age was 57.4 ± 9.7 and 61.9% (39/65) of patients had an established ILD. In RA-ILD group, SGRQ score was higher (p < 0.001) and SF-36 physical functioning score was lower (p = 0.02) than CTD-ILD group. In RA group, there was a significant correlation between FVC and SF-36 role functioning/physical score (r = 0.724, p = 0.012). In CTD group, SF-36 general health score was correlated with both FVC (r = 0.441, p = 0.045) and DLco (r = 0.485, p = 0.035), and also SF-36 physical functioning score was correlated with FVC (r = 0.441, p = 0.040). PROs were found to be similar between ILD and non-ILD patients. SF-36 QoL total and SGRQ outcomes were worse in non-ILD group. We concluded that PROs could be used to evaluate health-related quality of life (HRQoL) in RA- or CTD-related ILD. The physical health determinants of HRQoL are measurably worse in RA-ILD patients than in CTD patients. But, PROs may not be very helpful in differentiating patients with cough and/or shortness of breath due to ILD or non-ILD causes in RA/CTD.
• HRQoL may be affected differently among specific subtypes of ILD.
• PROs can be used to evaluate dyspnea and function of patients with RA- or CTD-related ILD but are not distinguished from patients with cough and/or shortness of breath due to non-ILD causes in RA/CTD.
Tài liệu tham khảo
Bryson T, Sundaram B, Khanna D, Kazerooni EA (2014) Connective tissue disease-associated interstitial pneumonia and idiopathic interstitial pneumonia: similarity and difference. Semin Ultrasound CT MR 35(1):29–38. https://doi.org/10.1053/j.sult.2013.10.010
Wallace B, Vummidi D, Khanna D (2016) Management of connective tissue diseases associated interstitial lung disease: a review of the published literature. Curr Opin Rheumatol 28(3):236–245. https://doi.org/10.1097/BOR.0000000000000270
de Lauretis A, Veeraraghavan S, Renzoni E (2011) Review series: aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ? Chron Respir Dis 8(1):53–82. https://doi.org/10.1177/1479972310393758
Kinder BW, Collard HR, Koth L, Daikh DI, Wolters PJ, Elicker B, Jones KD, King TE Jr (2007) Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med 176(7):691–697. https://doi.org/10.1164/rccm.200702-220OC
Cotes JE, Chinn DJ, Quanjer PH, Roca J, Yernault JC (1993) Standardization of the measurement of transfer factor (diffusing capacity). Report working party standardization of lung function tests, European community for steel and coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 16:41–52
Akira M, Sakatani M, Hara H (1999) Thin-section CT findings in rheumatoid arthritis-associated lung disease: CT patterns and their courses. J Comput Assist Tomogr 23(6):941–948. https://doi.org/10.1097/00004728-199911000-00021
Walsh SL, Sverzellati N, Devaraj A, Keir GJ, Wells AU, Hansell DM (2014) Connective tissue disease related fibrotic lung disease: high resolution computed tomographic and pulmonary function indices as prognostic determinants. Thorax 69(3):216–222. https://doi.org/10.1136/thoraxjnl-2013-203843
Goh NS, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM, Corte TJ, Sander CR, Ratoff J, Devaraj A, Bozovic G, Denton CP, Black CM, du Bois RM, Wells AU (2008) Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 177(11):1248–1254. https://doi.org/10.1164/rccm.200706-877OC
Dowman LM, McDonald CF, Hill CJ, Lee AL, Barker K, Boote C, Glaspole I, Goh NSL, Southcott AM, Burge AT, Gillies R, Martin A, Holland AE (2017) The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial. Thorax 72(7):610–619. https://doi.org/10.1136/thoraxjnl-2016-208638
Garin MC, Highland KB, Silver RM, Strange C (2009) Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma. J Rheumatol 36(2):330–336. https://doi.org/10.3899/jrheum.080447
Vandecasteele E, De Pauw M, De Keyser F, Decuman S, Deschepper E, Piette Y, Brusselle G, Smith V (2016) Six-minute walk test in systemic sclerosis: a systematic review and meta-analysis. Int J Cardiol 212:265–273. https://doi.org/10.1016/j.ijcard.2016.03.084
Wells AU (2007) Pulmonary function tests in connective tissue disease. Semin Respir Crit Care Med 28(4):379–388. https://doi.org/10.1055/s-2007-985610
Ciancio N, Pavone M, Torrisi SE, Vancheri A, Sambataro D, Palmucci S, Vancheri C, Di Marco F, Sambataro G (2019) Contribution of pulmonary function tests (PFTs) to the diagnosis and follow up of connective tissue diseases. Multidiscip Respir Med 14:17. https://doi.org/10.1186/s40248-019-0179-2
Saketkoo LA, Mittoo S, Frankel S, LeSsage D, Sarver C, Phillips K, Strand V, Matteson EL, Group OCTD-ILDW, Group OCTD-ILDW (2014) Reconciling healthcare professional and patient perspectives in the development of disease activity and response criteria in connective tissue disease-related interstitial lung diseases. J Rheumatol 41(4):792–798. https://doi.org/10.3899/jrheum.131251
Khanna D, Mittoo S, Aggarwal R, Proudman SM, Dalbeth N, Matteson EL, Brown K, Flaherty K, Wells AU, Seibold JR, Strand V (2015) Connective tissue disease-associated Interstitial lung diseases (CTD-ILD) - report from OMERACT CTD-ILD working group. J Rheumatol 42(11):2168–2171. https://doi.org/10.3899/jrheum.141182
Khanna D, Clements PJ, Furst DE, Chon Y, Elashoff R, Roth MD, Sterz MG, Chung J, FitzGerald JD, Seibold JR, Varga J, Theodore A, Wigley FM, Silver RM, Steen VD, Mayes MD, Connolly MK, Fessler BJ, Rothfield NF, Mubarak K, Molitor J, Tashkin DP (2005) Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the scleroderma lung study. Arthritis Rheum 52(2):592–600. https://doi.org/10.1002/art.20787
Kendrick KR, Baxi SC, Smith RM (2000) Usefulness of the modified 0-10 Borg scale in assessing the degree of dyspnea in patients with COPD and asthma. J Emerg Nurs 26(3):216–222. https://doi.org/10.1016/s0099-1767(00)90093-x
Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA (1999) Usefulness of the medical research council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54(7):581–586. https://doi.org/10.1136/thx.54.7.581
Suzuki A, Kondoh Y, Swigris JJ, Ando M, Kimura T, Kataoka K, Yamano Y, Furukawa T, Numata M, Sakamoto K, Hasegawa Y (2018) Performance of the St George’s Respiratory Questionnaire in patients with connective tissue disease-associated interstitial lung disease. Respirology. 23:851–859. https://doi.org/10.1111/resp.13293
Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID (2003) Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax 58(4):339–343. https://doi.org/10.1136/thorax.58.4.339
Chang JA, Curtis JR, Patrick DL, Raghu G (1999) Assessment of health-related quality of life in patients with interstitial lung disease. Chest 116(5):1175–1182. https://doi.org/10.1378/chest.116.5.1175
Warrick JH, Bhalla M, Schabel SI, Silver RM (1991) High resolution computed tomography in early scleroderma lung disease. J Rheumatol 18(10):1520–1528
Salaffi F, Carotti M, Di Donato E, Di Carlo M, Ceccarelli L, Giuseppetti G (2016) Computer-aided tomographic analysis of interstitial lung disease (ILD) in patients with systemic sclerosis (SSc). Correlation with pulmonary physiologic tests and patient-centred measures of perceived dyspnea and functional disability. PLoS One 11(3):e0149240. https://doi.org/10.1371/journal.pone.0149240
Natalini JG, Swigris JJ, Morisset J, Elicker BM, Jones KD, Fischer A, Collard HR, Lee JS (2017) Understanding the determinants of health-related quality of life in rheumatoid arthritis-associated interstitial lung disease. Respir Med 127:1–6. https://doi.org/10.1016/j.rmed.2017.04.002
Lubin M, Chen H, Elicker B, Jones KD, Collard HR, Lee JS (2014) A comparison of health-related quality of life in idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. Chest 145(6):1333–1338. https://doi.org/10.1378/chest.13-1984
Ware JE Jr (2000) SF-36 health survey update. Spine (Phila Pa 1976) 25(24):3130–3139. https://doi.org/10.1097/00007632-200012150-00008
Matcham F, Scott IC, Rayner L, Hotopf M, Kingsley GH, Norton S, Scott DL, Steer S (2014) The impact of rheumatoid arthritis on quality-of-life assessed using the SF-36: a systematic review and meta-analysis. Semin Arthritis Rheum 44(2):123–130. https://doi.org/10.1016/j.semarthrit.2014.05.001
Chaigne B, Finckh A, Alpizar-Rodriguez D, Courvoisier D, Ribi C, Chizzolini C (2017) Differential impact of systemic lupus erythematosus and rheumatoid arthritis on health-related quality of life. Qual Life Res 26(7):1767–1775. https://doi.org/10.1007/s11136-017-1534-4
Yazdani A, Singer LG, Strand V, Gelber AC, Williams L, Mittoo S (2014) Survival and quality of life in rheumatoid arthritis-associated interstitial lung disease after lung transplantation. J Heart Lung Transplant 33(5):514–520. https://doi.org/10.1016/j.healun.2014.01.858
Beretta L, Santaniello A, Lemos A, Masciocchi M, Scorza R (2007) Validity of the Saint George's Respiratory Questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis. Rheumatology (Oxford) 46(2):296–301. https://doi.org/10.1093/rheumatology/kel221
Celebi Sözener Z, Karabıyıkoğlu G, Düzgün N (2010) Evaluation of the functional parameters in scleroderma cases with pulmonary involvement. Tuberk Toraks 58(3):235–241
Pelrine ER, Ah-Kioon MD, Zhang M, Barrat FJ, Spiera RF, Gordon JK (2016) Musculoskeletal involvement in SSc is associated with worse scores on short form-36 and scleroderma health assessment questionnaire and lower tumor necrosis factor-α gene expression in peripheral blood mononuclear cells. Hss j 12(3):255–260. https://doi.org/10.1007/s11420-016-9515-7
Wallace B, Kafaja S, Furst DE, Berrocal VJ, Merkel PA, Seibold JR, Mayes MD, Khanna D (2015) Reliability, validity and responsiveness to change of the Saint George's Respiratory Questionnaire in early diffuse cutaneous systemic sclerosis. Rheumatology (Oxford) 54(8):1369–1379. https://doi.org/10.1093/rheumatology/keu456